U.S. flag

An official website of the United States government

NM_198578.4(LRRK2):c.4894G>C (p.Glu1632Gln) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Oct 26, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003396412.2

Allele description [Variation Report for NM_198578.4(LRRK2):c.4894G>C (p.Glu1632Gln)]

NM_198578.4(LRRK2):c.4894G>C (p.Glu1632Gln)

Gene:
LRRK2:leucine rich repeat kinase 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
12q12
Genomic location:
Preferred name:
NM_198578.4(LRRK2):c.4894G>C (p.Glu1632Gln)
HGVS:
  • NC_000012.12:g.40320054G>C
  • NG_011709.1:g.100044G>C
  • NM_198578.4:c.4894G>CMANE SELECT
  • NP_940980.4:p.Glu1632Gln
  • NC_000012.11:g.40713856G>C
  • NM_198578.3:c.4894G>C
Protein change:
E1632Q
Links:
dbSNP: rs200580973
NCBI 1000 Genomes Browser:
rs200580973
Molecular consequence:
  • NM_198578.4:c.4894G>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004122230Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Oct 26, 2023)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Deep sequencing of the LRRK2 gene in 14,002 individuals reveals evidence of purifying selection and independent origin of the p.Arg1628Pro mutation in Europe.

Rubio JP, Topp S, Warren L, St Jean PL, Wegmann D, Kessner D, Novembre J, Shen J, Fraser D, Aponte J, Nangle K, Cardon LR, Ehm MG, Chissoe SL, Whittaker JC, Nelson MR, Mooser VE.

Hum Mutat. 2012 Jul;33(7):1087-98. doi: 10.1002/humu.22075. Epub 2012 Apr 4.

PubMed [citation]
PMID:
22415848
PMCID:
PMC3370131

Genetic Identification in Early Onset Parkinsonism among Norwegian Patients.

Gustavsson EK, Trinh J, McKenzie M, Bortnick S, Petersen MS, Farrer MJ, Aasly JO.

Mov Disord Clin Pract. 2017 Jul-Aug;4(4):499-508. doi: 10.1002/mdc3.12501.

PubMed [citation]
PMID:
30363439
PMCID:
PMC6174458
See all PubMed Citations (3)

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV004122230.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

Variant summary: LRRK2 c.4894G>C (p.Glu1632Gln) results in a conservative amino acid change located in the C-terminal of Roc (COR) domain (IPR032171) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2.8e-05 in 249712 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.4894G>C has been reported in the literature in individuals affected with dementia with Lewy bodies or chronic obstructive pulmonary disease (Rubio_2012, Keogh_2018). These reports do not provide unequivocal conclusions about association of the variant with Parkinson Disease 8, Autosomal Dominant. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 22415848, 30363439, 29332010). One submitter has cited clinical-significance assessments for this variant to ClinVar after 2014 and has classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024